Marking 11 years of pioneering efforts in precision medicine and genomics, Sidra Medicine, a member of Qatar Foundation, is set to host the much-anticipated Precision Medicine and the Future of Genomics (PMFG) Summit 2025 from 2–4 December 2025 at the Qatar National Convention Centre (QNCC).
Since introducing the first precision medicine symposium in the Middle East in 2014, Sidra Medicine has been at the forefront of regional and global conversations on personalized healthcare. This year’s edition will spotlight three transformative themes: AI in Genomics, Clinical Trials, and Precision Medicine Implementation.
“Qatar remains at the forefront of medical transformation, and Sidra Medicine continues to play a catalyst role in shaping the future of precision medicine both regionally and internationally. This year’s themes represent our continued commitment to bridging research and clinical care, accelerating innovation, and shaping a more precise and inclusive future in healthcare. Through a robust program of dynamic discussions, hands-on masterclasses, and groundbreaking presentations, we look forward to welcoming the next wave of healthcare innovation.”
— Khalid Fakhro, Chief Research Officer, Sidra Medicine
“With a focus on Genomics and AI Innovation, Clinical Trials and Real-World Implementation, and Population Genomics and Future Frontiers, PMFG 2025 will explore the latest breakthroughs shaping the future of personalized healthcare, foster impactful collaborations that translate ideas into real-world solutions, and define actionable strategies to accelerate progress in precision medicine.”
— Sonia Davila, Executive Director of Translational Medicine, Sidra Medicine
The opening plenary at PMFG 2025 will be delivered by Stephen Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine (RCIGM), USA, and a member of Sidra Medicine’s Board of Governors. Sidra Medicine recently became the first international site to implement RCIGM’s genome-based newborn screening program, BeginNGS, which will form the foundation for the region’s first large-scale newborn genome screening research initiative.
“PMFG 2025 marks 11 years of trailblazing research, driving breakthroughs that redefine patient care. The Summit brings together global leaders in healthcare industry, translational research, advanced technologies, and policy to share knowledge, forge partnerships, and drive the advancement of genomic research towards the next-generation of precision medicine solutions.”— Ammira Akil, Principal Investigator, Sidra Medicine
Key knowledge partners for PMFG 2025 include the Qatar Precision Health Institute, Children’s Hospital of Philadelphia, Mass General Brigham Hospital, and Great Ormond Street Hospital for Children. Wellness support comes from Zulal Wellness Resort by Chiva-Som, while diamond sponsors include MedTech Corporation and Illumina.
The summit is open to healthcare professionals, scientists, researchers, academic institutions, policymakers, patient advocates, and technology solution providers from around the world.